
    
      A single-dose, three period, complete cross-over study to evaluate the relative
      bioavailability, pharmacokinetics, safety and tolerability of two candidate tablet
      formulations of ABT-072 when compared to that of the original capsule formulation suspended
      in liquid as a reference.
    
  